(Q39146473)

9 September 2017

MLH1 as a direct target of MiR-155 and a potential predictor of favorable prognosis in pancreatic cancer (English)

1 reference

9 September 2017

1 reference

Wen-Jing Liu

1

1 reference

9 September 2017

Yu-Pei Zhao

2

1 reference

9 September 2017

Tai-Ping Zhang

3

1 reference

9 September 2017

Li Zhou

4

1 reference

9 September 2017

Quan-Cai Cui

5

1 reference

9 September 2017

Wei-Xun Zhou

6

1 reference

9 September 2017

Lei You

7

1 reference

9 September 2017

Ge Chen

8

1 reference

9 September 2017

Hong Shu

9

1 reference

9 September 2017

29 May 2013

1 reference

Journal of Gastrointestinal Surgery

9 September 2017

1 reference

9 September 2017

17

1 reference

9 September 2017

8

1 reference

9 September 2017

1399-1405

1 reference

https://scigraph.springernature.com/pub.10.1007/s11605-013-2230-5

9 September 2017

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Therapeutic targeting of the DNA mismatch repair pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Is reduced expression of mismatch repair genes MLH1 and MSH2 in patients with sporadic colorectal cancer related to their prognosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: clinical and prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Loss of hMLH1 expression is associated with less aggressive clinicopathological features in sporadic endometrioid endometrial adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Modulation of mismatch repair and genomic stability by miR-155

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

HOXA5 regulates hMLH1 expression in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Human mismatch repair gene, MLH1, is transcriptionally repressed by the hypoxia-inducible transcription factors, DEC1 and DEC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Molecular characterisation of pancreatic ductal adenocarcinoma in patients under 40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Down-regulation of DNA mismatch repair enhances initiation and growth of neuroblastoma and brain tumour multicellular spheroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Expression profiling identifies microRNA signature in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Inactivation of Ink4a/Arf leads to deregulated expression of miRNAs in K-Ras transgenic mouse model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Clinical and pathologic prognostic factors for curative resection for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2230-5

Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer

21 January 2018

1 reference

12 December 2020

Expression of the DNA mismatch repair proteins (hMLH1 and hMSH2) in infiltrating pancreatic cancer and its relation to some phenotypic features

1 reference

12 December 2020

Prognostic implications of lymph node metastases in carcinoma of the body and tail of the pancreas

1 reference

12 December 2020

MLH1 mismatch repair gene product is associated with apoptotic potential of urothelial bladder carcinomas

1 reference

12 December 2020

Frequent alterations of hMLH1 and RBSP3/HYA22 at chromosomal 3p22.3 region in early and late-onset breast carcinoma: clinical and prognostic significance

1 reference

12 December 2020

Defective DNA mismatch repair in long-term (> or =3 years) survivors with pancreatic cancer

1 reference

12 December 2020

Not hMSH2 but hMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability

1 reference

12 December 2020

Reduced MLH1 expression after chemotherapy is an indicator for poor prognosis in esophageal cancers

1 reference

12 December 2020

Negative hMSH2 protein expression in pancreatic carcinoma may predict a better prognosis of patients.

1 reference

12 December 2020

Prognostic implications of hMLH1 and p53 immunohistochemical status in right-sided colon cancer

1 reference

12 December 2020

Reduced MLH1 expression in breast tumors after primary chemotherapy predicts disease-free survival

1 reference

12 December 2020

10.1007/S11605-013-2230-5

Identifiers

DOI

1 reference

9 September 2017

1 reference